Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor.
about
Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.Antiinflammatory therapies for cystic fibrosis: past, present, and future.Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model.Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulationDelivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation.Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lung.A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation.
P2860
Q36114167-4BED9626-E09E-4AFA-8172-67380EAFAC01Q36174470-15D4A02D-E40F-42C0-9645-6F377E4D4AC8Q37731798-24564926-D3E2-4495-B68A-D3033A440FADQ37774788-0EF4E54E-9B4D-44DD-8554-F3C0C3287F5BQ37936542-1E4ECFF0-D8E0-4AFC-B3E2-EBCBCBC138D4Q39529387-8DA6D778-6587-4820-9721-36F8B38655EFQ39810189-909B2A63-2A2A-4E90-8242-06958F2184B2Q39928680-F5E8D103-CDD7-4516-8109-7782C951AC6AQ41208772-BFFA9AC5-5C5F-472A-9BA2-EB3303616A47Q41431968-0D6E375D-4951-4CEB-B8FB-DA7F7881DD21Q42114465-4E09C66A-670C-4DE9-B48F-EC92CB2399C4
P2860
Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Pulmonary deposition and disap ...... leucocyte protease inhibitor.
@en
type
label
Pulmonary deposition and disap ...... leucocyte protease inhibitor.
@en
prefLabel
Pulmonary deposition and disap ...... leucocyte protease inhibitor.
@en
P2093
P2860
P356
P1433
P1476
Pulmonary deposition and disap ...... leucocyte protease inhibitor.
@en
P2093
P2860
P304
P356
10.1136/THX.50.6.645
P407
P577
1995-06-01T00:00:00Z